AMRX

AmnealA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

earningsSentiment +75

Source

External coverage

Decided

2026-05-01

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

The issuer-specific impact hint points to AMRX, and the title/summary combine an acquisition to build a 'global biosimilar leader' with strong preliminary results and raised FY2026 guidance.

View event details

Sentiment decomposition

0.0

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for AMRX. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-05-23 • Updated scheduledSource: News desk